FDA Approved: VIJOICE — Original Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

The FDA approved the original application for VIJOICE (alpelisib) by Novartis for adult patients with HR-positive, HER2-negative advanced or metastatic breast c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• VIJOICE (ALPELISIB)

Snippet

ORIG AP for VIJOICE (ALPELISIB)